Evaluating the cost-effectiveness of an early detection of Parkinson's disease through innovative technology

被引：6
|
作者：
Munoz, David A. [1 ,2 ]
Kilinc, Mehmet Serdar [1 ,2 ]
Nembhard, Harriet B. [1 ,2 ]
Tucker, Conrad [1 ,3 ]
Huang, Xuemei [4 ]
机构：
[1] Penn State Univ, Dept Ind & Mfg Engn, University Pk, PA 16802 USA
[2] Penn State Univ, Clin & Translat Sci Inst, University Pk, PA 16802 USA
[3] Penn State Univ, Dept Engn Design, University Pk, PA 16802 USA
[4] Penn State Univ, Coll Med, Hershey, PA USA
来源：
ENGINEERING ECONOMIST | 2017年 / 62卷 / 02期
基金：
美国国家卫生研究院;
关键词：
WILLINGNESS-TO-PAY; DEEP BRAIN-STIMULATION; ADJUSTED LIFE YEAR; QUALITY-OF-LIFE; EARLY-DIAGNOSIS; EFFECTIVENESS THRESHOLD; HEALTH; RECOMMENDATIONS; NICE;
D O I：
10.1080/0013791X.2017.1294718
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
Early detection of Parkinson's disease (PD) is critically important because it can increase patient quality of life and save treatment costs. An innovative approach for early detection of PD is to use nonwearable sensors that are capable of capturing skeletal joint data. This article evaluates the cost-effectiveness of this sensor-based intervention considering the quality-adjusted life years (QALYs) and the associated costs. The results indicate that the intervention would be cost-effective if devices were deployed for community health screening in public places such as health fairs and pharmacies.
引用
收藏
页码：180 / 196
页数：17
相关论文
共 50 条
  • [21] Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease
    Dams, J.
    Siebert, U.
    Bornschein, B.
    Volkmann, J.
    Deuschl, G.
    Oertel, W. H.
    Reese, J. P.
    Dodel, R.
    MOVEMENT DISORDERS, 2012, 27 : S155 - S156
  • [22] Methods for evaluating the cost-effectiveness of innovative projects in nuclear power
    A. N. Karkhov
    Atomic Energy, 2009, 107 : 363 - 368
  • [23] Methods for evaluating the cost-effectiveness of innovative projects in nuclear power
    Karkhov, A. N.
    ATOMIC ENERGY, 2009, 107 (06) : 363 - 368
  • [24] COST EFFECTIVENESS OF EARLY TREATMENT OF PARKINSON'S DISEASE IN MEXICO
    Marquez, M.
    Diaz, J. P.
    Pizarro, M.
    Ibarra, A.
    Cervantes, A.
    Rodriguez, M.
    Soto, H.
    VALUE IN HEALTH, 2015, 18 (03) : S283 - A284
  • [25] Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis
    Fundament, Tomasz
    Eldridge, Paul R.
    Green, Alexander L.
    Whone, Alan L.
    Taylor, Rod S.
    Williams, Adrian C.
    Schuepbach, W. M. Michael
    PLOS ONE, 2016, 11 (07):
  • [26] Cost-effectiveness of screening and treating early Alzheimer's disease
    Araki, SS
    Kuntz, KM
    Neumann, PJ
    MEDICAL DECISION MAKING, 1998, 18 (04) : 456 - 456
  • [27] COST-BENEFIT AND COST-EFFECTIVENESS - METHODOLOGIES FOR EVALUATING INNOVATIVE PHARMACEUTICAL SERVICES
    MCGHAN, WF
    ROWLAND, CR
    BOOTMAN, JL
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (02): : 133 - 140
  • [28] EARLY COST-EFFECTIVENESS ANALYSIS OF AI-ENHANCED REMOTE MONITORING SOLUTIONS FOR TIMELY DETECTION OF ADVANCED PARKINSON'S DISEASE IN FINLAND
    Godoy, C.
    Makitie, L.
    Koivu, M.
    Bakker, L.
    Uyl-De Groot, C. A.
    van Deen, W.
    Redekop, K.
    VALUE IN HEALTH, 2024, 27 (12)
  • [29] Early Detection of Parkinson's disease through Voice
    Vikas
    Sharma, R. K.
    2014 INTERNATIONAL CONFERENCE ON ADVANCES IN ENGINEERING AND TECHNOLOGY (ICAET), 2014,
  • [30] Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan
    Shimbo, T
    Hira, K
    Takemura, M
    Fukui, T
    PHARMACOECONOMICS, 2001, 19 (08) : 875 - 886
12345